Company Profile

ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE629.00-4.5 (-0.71 % )
PREV CLOSE (Rs.) 633.50
OPEN PRICE (Rs.) 634.40
BID PRICE (QTY) 627.00 (5 )
OFFER PRICE (QTY) 628.50 (11 )
VOLUME 494
TODAY'S LOW / HIGH (Rs.)626.30 637.85
52 WK LOW / HIGH (Rs.)571.5 817.65
NSE629.95 -7.85 (-1.23 % )
PREV CLOSE(Rs.) 637.80
OPEN PRICE (Rs.) 637.85
BID PRICE (QTY) 629.05 (2 )
OFFER PRICE (QTY) 630.00 (5 )
VOLUME 1691
TODAY'S LOW / HIGH(Rs.) 629.00 637.85
52 WK LOW / HIGH (Rs.)572.5 820

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 3.10726
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 38.61
ROCE (%) 35.45
Incorporation Year : 2007

Management Info :

- Chairman Amit Indubhushan Bakshi - Managing Director

Registered Office :

Address : 8th Floor, Commerce House I V,Beside Shell Petrol Pump,100 Feet Road, Prahladnagar,
Ahmedabad,
Gujarat-380015

Phone : 079 3045 1111

Website : www.eris.co.in

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
19Mar03-19-2019$ Announcement under Regulation 30 (LODR)-Resignation of Director Announcement under Regulati
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, It is hereby informed that Mr. Himanshu Shah, Executive Director of the company has resigned from the membership of the Board. The said resignation shall come into effect from the close of the business hours on 16th July, 2019.
In accordance with the requirements of Regulation 30 and other..
05Mar03-05-2019$Eris Lifesciences informs about schedule of analyst meet Eris Lifesciences informs ab

Eris Lifesciences has informed about Schedule of Analyst / Institutional Investor Meeting(s).

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences has informed about Schedule of Analyst / Inst..
22Feb02-22-2019$Eris Lifesciences informs about analyst meeting Eris Lifesciences informs ab

Eris Lifesciences has informed about schedule of analyst / institutional investor meeting.

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences has informed about schedule of analyst / inst..
18Feb02-18-2019$ Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Announcement under Regulati
It is hereby informed that an allotment of 2161 equity shares of Re. 1/- each at a premium of Rs. 450.04/- per share has been made on 18.02.2019, pursuant to exercise of options under its ESOP-2017 Scheme. The paid up share capital of the Company has accordingly been increased from Rs. 13,75,17,622/- (13,75,17,622 equity shares of Re. 1/- each) to Rs. 13,75,19,783/- (13,75,19,783 equity shares of Re. 1/- each).
It is hereby informed that an allotment of 2161 equity shares o..
30Jan01-30-2019$ SUBMISSION OF AMENDED CODE OF PRACTICES AND PROCEDURES FOR FAIR DISCLOSURE OF UNPUBLISHED PRICE SENSITIVE INFORMATION SUBMISSION OF AMENDED CODE
In compliance with Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015 ('the Regulations'), the Board of Directors of the Company in their meeting held on 29th January, 2019 had amended the existing Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. In Compliance with the Regulation 8(2) of the Regulations, please find enclosed a copy of the aforesaid code for your information and records.
In compliance with Regulation 8 of the SEBI (Prohibition of Ins..
Financials More
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit788.772936.55
Gross Profit 872.68 3118.89
Operating Profit 1007.553441.1
Net Sales 2308.037606.01
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Piramal Enterprises (BSE)
 2615.25 (1.60%)
M.Cap ( in Cr)
48196.31
Valiant Organics (BSE)
 1575.00 (1.94%)
M.Cap ( in Cr)
923.64
Sanofi India (BSE)
 5590.00 (0.53%)
M.Cap ( in Cr)
12874.12
Torrent Pharma (BSE)
 1882.50 (1.02%)
M.Cap ( in Cr)
31853.54
Glenmark Pharma (BSE)
 647.00 (1.69%)
M.Cap ( in Cr)
18221.01
Shareholding Pattern More
PROMOTERS 56.04 %
NON-INSTITUTION 24.19 %
MUTUAL FUNDS/UTI 10.85 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes

Open A

New Account

Name
Email
Mobile Number
City
Select Products You Are Interested